An American woman stands in front of a camera, with chilli oil, rice, garlic, ginger and spring onions laid out on a counter ...

Melbourne has adopted a floral emblem. Of the 700 local native species, experts short-listed nine that celebrate the city’s ...

On Saturday, The Independent reported that a Rozonda Thomas of Stone Mountain, Georgia, made donations to the Trump National ...

The remaining members of beloved pop and R B group TLC are set to hit the road for a highly anticipated tour with Salt-N-Pepa and En Vogue.

"I made a mistake too many make: I did not read the fine print," the singer said in a March 28 Instagram post Toria Sheffield joined the PEOPLE editorial staff in 2024. Her work as a writer/editor has ...

TLC singer Rozonda “Chilli” Thomas clarified she wasn’t a supporter of Donald Trump after donating to the president’s campaign and resharing a conspiracy about Michelle Obama. “I WANT TO BE CLEAR: I ...

Grandpa Homemade Cheung Fun at Toa Payoh West Market & Food Centre serves chee cheong fun in unconventional colourful skins, including dragon fruit and spinach, paired with fillings like egg and ...

Discover What’s Streaming On: Joe Bradley is speaking out on Grace Lilly‘s second arrest in less than three months, as Lilly opened up in the latest episode of Southern Hospitality about her struggles ...

Matthew Herper covers medical innovation — both its promise and its perils. Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech ...

Retatrutide, an experimental diabetes drug produced by Eli Lilly, helped some trial participants lose over 15% of their body weight, according to results of a new study released by the drug ...

With shares up 20% over the past 12 months, Eli Lilly appears to have come out on top in the battle to dominate the weight-loss drug market, with rival Novo Nordisk sinking 52% over the same period.

Eli Lilly (LLY) is down to the $937 area as investors await an April FDA decision on its oral obesity pill, orforglipron. Moreover, shares of Eli Lilly rival Novo Nordisk (NVO) are down 25% year to ...